Medicine and Dentistry
Autologous Stem Cell Transplantation
100%
Overall Survival
62%
Follicular Lymphoma
62%
Myelodysplastic Syndrome
25%
Acute Myeloid Leukemia
25%
Hazard Ratio
25%
Event Free Survival
25%
Solid Malignant Neoplasm
25%
Adverse Outcome
25%
Hematology
12%
Rituximab
12%
Chemoimmunotherapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Follicular Lymphoma
62%
Overall Survival
62%
Randomized Clinical Trial
50%
Adverse Outcome
25%
Event Free Survival
25%
Myelodysplastic Syndrome
25%
Random Effects Model
25%
Acute Myeloid Leukemia
25%
Solid Malignant Neoplasm
25%
Rituximab
12%
Agricultural and Biological Sciences
Autologous Stem Cell Transplantation
100%
Confidence Interval
62%
Meta-Analysis
37%
Relative Risk
37%
Systematic Review
25%
Randomized Clinical Trials
25%
Clinical Trials
12%
Rituximab
12%